As with more traditional 3D printing technologies, an important part of bioprinting is the 3D printing material, meaning that there will be significant business opportunities for suppliers of biomatter for 3D printing, just as there is with the bioprinting process itself. For that reason, CELLINK and Rooster Bio teamed up to sell CELLINK’s affordable bioprinter and Rooster Bio’s biomaterials. That’s also why bioprinting firm Organovo has today announced that the launch of their subsidiary Samsara Sciences, Inc., which has begun commercial operations to provide human liver cells for in vivo and in vitro research applications.…
The original post Organovo’s Samsara to Sell Liver Cells for Bioprinting appeared first on 3D Printing Industry.